MedPath

Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors

Not Applicable
Recruiting
Conditions
Anxiety
Interventions
Other: TiMBRe
Other: Control
Registration Number
NCT05911269
Lead Sponsor
University of Michigan Rogel Cancer Center
Brief Summary

Demonstrate the feasibility of conducting an eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in adolescent and young adult (AYA) cancer survivors with clinically-relevant anxiety.

Detailed Description

Initially Sessions 7 and 8 were both body percussion; however, the 04FEB2025 changed this to Session 7 will be body percussion and session 8 will be selected by the participant. This will allow for more tailoring of the intervention.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • 15 - 39 years old
  • at least one month post cancer treatment
  • report clinically relevant anxiety in the past seven days (PROMIS Anxiety 4a scores ≥ 55)35
  • speak/read English.
Exclusion Criteria
  • prognosis less than 3 months
  • documentation of significant hearing impairment
  • plan to receive surgery, radiation, or chemotherapy for cancer treatment during the study period
  • plans in place to begin new psychosocial (i.e., cognitive behavioral therapy14 or mindfulness-based stress reduction15) or pharmacological treatments for anxiety during the study. Although, participants may continue psychosocial or pharmacological treatments for anxiety if the treatments were initiated at least eight weeks prior to study enrollment, the dose has not changed, and they report clinically relevant anxiety in the last week.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
TiMBReTiMBRean eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in AYA cancer survivors with clinically-relevant anxiety.
Attention-ControlControlStandard of care study staff calls and cancer survivorship resources
Primary Outcome Measures
NameTimeMethod
Acceptability of TiMBReup to 8 weeks post start of intervention

mean scores for the Acceptability E-scale Items are ≥ 4/5

Demand of TiMBReup to 3 years from start of study

percent of patients recruited over three years

Adherence to TiMBReFrom enrollment to end of treatment at 8 weeks

percent of TiMBRe participants to complete the baseline and 8 weeks patient report measures

Practicality of TiMBReFrom enrollment to end of treatment at 8 weeks

percent of TiMBRe group participants self-report practicing music-based relaxation skills for at least 10 minutes on at least three days per week

Secondary Outcome Measures
NameTimeMethod
Identification of facilitators and barriers to virtual TiMBRe participationup to 8 weeks post start of intervention

Interviews will be transcribed by a professional HIPAA compliant transcription agency. We will analyze interview data using inductive content analysis.74 Transcripts will be entered into NVivo Qualitative Data Analysis Software (QSR International, Melbourne, Australia). The study team will read transcripts to derive codes, discuss labels to group codes into categories, and identify major themes and corresponding exemplar quotes. The interviewer will write reflexive memos after each interview and review memos with corresponding audio recordings to discern linkages, gaps, and questions.

Change in Anxiety managementat baseline and eight weeks post initiation of treatment

determine the preliminary impact of the eight-week virtual TiMBRe intervention, relative to the control, on improving anxiety (PROMIS Anxiety 4a, 40.3 - 81.6; higher scores = worse anxiety) utilizing data collected at baseline, four weeks, and eight weeks. Reporting the change from baseline to eight weeks.

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath